MiR-196b-5p plays a central role in maintaining CSCs characteristics associated with resistance to cancer therapy by targeting STAT3 signaling pathway in colorectal cancer stem cells (Ren et al., 2017a). The gene discussed is STAT3; the disease is cancer.